首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝动脉化疗栓塞 ~(32)P午治疗原发性肝癌患者后sIL-2R、T淋巴细胞亚群改变
引用本文:毛华,赵敏芳,宋卫生,袁爱力.肝动脉化疗栓塞 ~(32)P午治疗原发性肝癌患者后sIL-2R、T淋巴细胞亚群改变[J].胃肠病学和肝病学杂志,1999(1).
作者姓名:毛华  赵敏芳  宋卫生  袁爱力
作者单位:第一军医大学珠江医院消化科!广州510282(毛华,宋卫生),第一军医大学珠江医院放疗科!广州510282(赵敏芳),第一军医大学南方医院全军消化疾病研究所(袁爱力)
摘    要:观测原发性肝癌患者经肝动脉化疗栓塞(TAE)+32P内照射治疗后免疫功能状态改变。方法检测23例TAN+32P治疗后原发性肝癌患者和20例健康献血员血液可溶性白细胞介素2受体(sIL-2R)、辅助T淋巴细胞、抑制T淋巴细胞。结果原发性肝癌患者Th细胞比健康对照组显著下降(P<0.05),sIL-2R、Ts细胞比健康对照组明显增高(P<0.05);TAE+32P治疗后原发性肝癌患者Th细胞明显增高(P<0.05),sIL-2R、Ts细胞非常显著降低(P<0.01)。结论测定TAE+32P治疗原发性肝癌患者血液中sIL-2R、Th、Ts细胞对判断患者免疫功能状态、疗效、预后有一定的价值。

关 键 词:原发性肝癌  TAE  32~P  sIL-2R  辅助T细胞  抑制T细胞

Alteration of soluble interleukin 2 receptor and T lymphocyte subsets in Patients with liver cancer after TAE ( 32)~P
Mao Hua, Zhao Minfang, Song Weisheng, at al.Alteration of soluble interleukin 2 receptor and T lymphocyte subsets in Patients with liver cancer after TAE ( 32)~P[J].Chinese Journal of Gastroenterology and Hepatology,1999(1).
Authors:Mao Hua  Zhao Minfang  Song Weisheng  at al
Abstract:Aim ln oafer to know immune state in patients with liver cancer after transcatheter hepatic artery embolization (TAE) 32P. Methods We determined serum soluble interleukin 2 receptor and T lylnphocyte subsets in 23 patients with liver cancer and 20 healthy subjects. Results The results showed that in patients with liver cancer HelP T cellsrmlower (P < 0. 05 ); sIL - 2R. Suppress T cells were significantly higher (P < 0. 05 ) than those in control group. The cells in patients with liver cancer became higher and sIL - 2R. Ts cells became lower remarkably(P < 0. 05. P < 0. 01 ). ConclusionMeasurement of Th.Ts cells and sIL - 2R after TAE 32P has certain value for evaluating immune state .treating effection andprognosis in patients with liver cancer.
Keywords:PHC  TAE  32~P  sIL-2R  Th  Ts
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号